Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $2.83 Billion |
|---|---|
| Enterprise Value | $-901,475,678.00 |
| Earnings per Share | $0.36 |
| Beta | 0.39 |
| Outstanding Shares | 1,767,202,139 |
| P/E Ratio | 12.82 |
|---|---|
| PEG | -0.98 |
| Price to Sales | 1.6 |
| Price to Book Ratio | 0.4 |
| Enterprise Value to Revenue | 4.09 |
| Enterprise Value to EBIT | 11.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.26 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
InnoCare Pharma Limited, a biopharmaceutical enterprise, specializes in the discovery, development, and commercialization of therapeutic agents for oncological and autoimmune disorders. Its lead product, Orelabrutinib, a BTK inhibitor, a...